Kathryn Elliott

4.6k total citations
58 papers, 3.3k citations indexed

About

Kathryn Elliott is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Kathryn Elliott has authored 58 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 16 papers in Physiology. Recurrent topics in Kathryn Elliott's work include Neuropeptides and Animal Physiology (14 papers), Pain Mechanisms and Treatments (13 papers) and Neuroscience and Neuropharmacology Research (8 papers). Kathryn Elliott is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Pain Mechanisms and Treatments (13 papers) and Neuroscience and Neuropharmacology Research (8 papers). Kathryn Elliott collaborates with scholars based in United States, United Kingdom and Australia. Kathryn Elliott's co-authors include Charles E. Inturrisi, Laura E. Chavez-Noriega, Edwin C. Johnson, Naohito Shimoyama, Megumi Shimoyama, Arturo Urrutia, James H. Crona, Amy Gorman, Mark Washburn and Kathleen M. Foley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Kathryn Elliott

58 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Elliott United States 29 1.6k 1.1k 1.1k 440 412 58 3.3k
Claire Gavériaux‐Ruff France 40 3.3k 2.1× 1.8k 1.6× 3.8k 3.4× 308 0.7× 387 0.9× 89 6.1k
Howard B. Gutstein United States 29 970 0.6× 636 0.6× 887 0.8× 268 0.6× 178 0.4× 65 2.4k
Toshiaki Minami Japan 30 1.2k 0.8× 1.7k 1.5× 1.4k 1.3× 483 1.1× 647 1.6× 213 3.7k
Carla Nau Germany 30 1.3k 0.8× 1.3k 1.1× 985 0.9× 197 0.4× 155 0.4× 52 3.0k
Alan Cowan United States 36 2.0k 1.3× 2.1k 1.8× 2.7k 2.4× 252 0.6× 542 1.3× 133 5.2k
Michael Brüss Germany 32 1.2k 0.8× 314 0.3× 1.1k 1.0× 160 0.4× 407 1.0× 117 3.4k
Hamid I. Akbarali United States 37 1.9k 1.2× 938 0.8× 1.2k 1.1× 93 0.2× 331 0.8× 129 3.8k
Elizabeth Matthews United States 27 1.7k 1.1× 1.4k 1.3× 1.3k 1.2× 104 0.2× 231 0.6× 70 3.1k
Dennis Paúl United States 25 978 0.6× 1.1k 1.0× 1.2k 1.1× 245 0.6× 188 0.5× 71 2.3k
Ricardo A. Cruciani United States 26 883 0.6× 336 0.3× 496 0.4× 474 1.1× 210 0.5× 71 2.4k

Countries citing papers authored by Kathryn Elliott

Since Specialization
Citations

This map shows the geographic impact of Kathryn Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Elliott more than expected).

Fields of papers citing papers by Kathryn Elliott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Elliott. The network helps show where Kathryn Elliott may publish in the future.

Co-authorship network of co-authors of Kathryn Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Elliott. A scholar is included among the top collaborators of Kathryn Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Elliott. Kathryn Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson‐Papp, Jessica, Susan Morgello, Florin Vaida, et al.. (2010). Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain. 151(3). 732–736. 33 indexed citations
2.
Robinson‐Papp, Jessica, Kathryn Elliott, & David M. Simpson. (2009). HIV-related neurocognitive impairment in the HAART era. Current HIV/AIDS Reports. 6(3). 146–152. 19 indexed citations
3.
Bertram, Lars, Mikko Hiltunen, Michele Parkinson, et al.. (2005). Family-Based Association between Alzheimer's Disease and Variants inUBQLN1. New England Journal of Medicine. 352(9). 884–894. 184 indexed citations
4.
Burton, David J., Hassan Abdulrazzak, Adam Knott, et al.. (2002). Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility. Biochemical Journal. 362(2). 443–443. 31 indexed citations
5.
Abdulrazzak, Hassan, Adam Knott, Kathryn Elliott, et al.. (2002). Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility. Biochemical Journal. 362(2). 443–451. 23 indexed citations
6.
Redwood, Charles, Kathryn Elliott, & Hugh Watkins. (1998). Defective inhibitory properties of human cardiac troponin I mutants that cause familial hypertrophic cardiomyopathy (FHC). Circulation. 98. 466–466. 4 indexed citations
7.
Elliott, Kathryn, et al.. (1998). 6-hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression. Journal of Molecular Neuroscience. 10(3). 251–260. 31 indexed citations
8.
Shimoyama, Megumi, Naohito Shimoyama, Charles E. Inturrisi, & Kathryn Elliott. (1997). Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain. 72(3). 375–382. 96 indexed citations
9.
Shimoyama, Naohito, Megumi Shimoyama, Charles E. Inturrisi, & Kathryn Elliott. (1996). Ketamine Attenuates and Reverses Morphine Tolerance in Rodents. Anesthesiology. 85(6). 1357–1366.. 106 indexed citations
10.
Elliott, Kathryn, et al.. (1995). N-Methyl-D-Aspartate (NMDA) Receptors, Mu and Kappa Opioid Tolerance, and Perspectives on New Analgesic Drug Development. Neuropsychopharmacology. 13(4). 347–356. 7 indexed citations
12.
Elliott, Kathryn. (1994). Other neurological complications of herpes zoster and their management. Annals of Neurology. 35(S1). S57–S61. 56 indexed citations
13.
Brodsky, Marina, et al.. (1994). Strain differences in the analgesic potency of morphine and in mu opioid receptor mRNA levels in adult male mice. Regulatory Peptides. 54(1). 33–34. 8 indexed citations
15.
Elliott, Kathryn. (1994). Taxonomy and Mechanisms of Neuropathic Pain. Seminars in Neurology. 14(3). 195–205. 24 indexed citations
16.
Elliott, Kathryn, et al.. (1993). Dextromethorphan attenuates and reverses morphine tolerance. The Society for Neuroscience Abstracts. 19. 1351. 5 indexed citations
17.
Elliott, Kathryn, et al.. (1993). Quantitation of NMDA receptor (NMDAR1) mRNA levels in the adult and developing rat CNS. Molecular Brain Research. 19(1-2). 93–100. 45 indexed citations
18.
Appleton, David R., et al.. (1991). Effects of gastrointestinal peptides on azoxymethane-treated colonic mucosa in vitro. Carcinogenesis. 12(11). 2017–2022. 5 indexed citations
19.
Elliott, Kathryn & Kathleen M. Foley. (1990). Pain Syndromes in the Cancer Patient. Journal of Psychosocial Oncology. 8(2-3). 11–45. 4 indexed citations
20.
Jessopp, Lynda, et al.. (1985). Well woman care: whose responsibility?. PubMed Central. 35(279). 490–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026